LinkedIn · Jul 2026
Max Williamson says Aidy was vetted and recognized by the Crohn's & Colitis Foundation, and frames the service as a free SMS/app-based support tool for Crohn's and ulcerative colitis patients.
Mobile app helping people better manage chronic health conditions
Company research
Public company, workplace, funding, and market signals
Updated Jul 30, 2026
Overview
Aidy is a YC W24, San Francisco-based digital health startup whose current public product is an SMS-first and app-based companion for people with Crohn’s disease and ulcerative colitis. It helps users track symptoms, diet, meds, biologic schedules, and coverage requirements, then turns that data into reports and support for care teams; Aidy monetizes through B2B partnerships with health plans, employers, researchers, pharma patient-services teams, medical affairs/HEOR groups, and specialty pharmacies. Public records also show earlier Aidy/grants/policy pivots, so older traces should be treated carefully.
Primary product
SMS-first IBD companion app and patient-support platform for Crohn’s disease and ulcerative colitis
Founded
2024
Headquarters
San Francisco, California, United States
Team size
1-10
Industry
Technology, Information and Internet
Sub-industry
Open Positions
0 jobs at Aidy
No open positions
Check back later for new openings